CatherineLumleyMD
Otolaryngology (ENT) • Chapel Hill, NCHead & Neck Microvascular Surgery, Head & Neck Oncologic Surgery
Assistant Professor
Dr. Lumley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
University of North Carolina Hospitals
101 Manning Dr
Chapel Hill, NC 27514
Summary
- Dr. Catherine Lumley is an otolaryngologist in Chapel Hill, NC and is affiliated with University of North Carolina Hospitals. She received her medical degree from Wayne State University School of Medicine and has been in practice 5 years. She specializes in head & neck microvascular surgery and head & neck oncologic surgery and is experienced in cutaneous squamous cell carcinoma, head and neck oncology, head and neck oncology and microvascular reconstruction, head and neck reconstructive surgery, and oral cavity cancer. She has more than 10 publications and over 100 citings.
Education & Training
University of North Carolina HospitalsFellowship, Otolaryngology - Head and Neck Surgery, 2019- University of North Carolina HospitalsOtolaryngology (ENT), 2019
MedStar Health/Georgetown University HospitalResidency, Otolaryngology - Head and Neck Surgery, 2013 - 2018
Wayne State University School of MedicineClass of 2013
Certifications & Licensure
NC State Medical License 2018 - 2025
DC State Medical License 2013 - 2018
VA State Medical License 2013 - 2014- American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
Publications & Presentations
PubMed
- Comparison of surgical margins and adjuvant therapy for head and neck cancer by hospital type.Douglas R Farquhar, Nicholas R Lenze, Jason Tasoulas, Siddharth Sheth, Jose P Zevallos
Translational Cancer Research. 2024-09-30 - 2 citationsEffect of distance of treatment center on survival for HPV-negative head and neck cancer patients.Douglas R Farquhar, Maheer M Masood, Nicholas R Lenze, Jason Tasoulas, Siddharth Sheth
Head & Neck. 2023-12-01 - 6 citationsA phase 2 study of neoadjuvant chemotherapy plus durvalumab in resectable locally advanced head and neck squamous cell carcinoma.Shetal A Patel, Michael K Gibson, Allison Deal, Siddharth Sheth, Hillary Heiling
Cancer. 2023-11-01
Press Mentions
Clinical Trial Improves Man’s Quality of Life with Tongue CancerJuly 7th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
